Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 5 · newest first

  1. CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapyCancer Treatment and Research Communications · 2026
  2. SLFN5 as a dual-function oncogene and immune regulator: A pan-cancer multi-omics analysis linking prognosis, immune evasion, and therapeutic vulnerabilityCancer Treatment and Research Communications · 2026
  3. Exploring decisional needs of adults considering first line treatment for advanced EGFR+ lung cancer: An interpretive descriptive studyCancer Treatment and Research Communications · 2026
  4. Comprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expressionCancer Treatment and Research Communications · 2026
  5. Molecular and clinicopathological insights into oral squamous cell carcinoma: Exploring oxidative stress, ferroptosis, circadian regulation, and novel biomarkersCancer Treatment and Research Communications · 2026
  6. Towards identification of novel inhibitors of EGFR mutants through in-silico approachCancer Treatment and Research Communications · 2026
  7. Molecular functions, clinical correlates, and therapeutic prospects of B7-H3 expression in colorectal cancer: A systematic reviewCancer Treatment and Research Communications · 2026
  8. Human host factors Secretory leukocyte protease inhibitor and Annexin A2 modulate the presence of human papillomavirus DNA, but not Epstein–Barr virus, in nasopharyngeal carcinoma from non-endemic regionsCancer Treatment and Research Communications · 2026
  9. Burden and future trajectory of pancreatic cancer in the EU-28, 1990–2023: A GBD 2023 analysis with projections to 2050Cancer Treatment and Research Communications · 2026
  10. Association of glucagon-like peptide 1 receptor and the aggressiveness of extrahepatic cholangiocarcinomaCancer Treatment and Research Communications · 2026
  11. Financial burden of immune checkpoint inhibitor maintenance therapy in Japan: a real-world cost analysis from an academic medical centerCancer Treatment and Research Communications · 2026
  12. Expression of carbonic Anhydrase IX in extramural venous invasion tissues of esophageal squamous cell carcinoma may provide additional prognostic stratificationCancer Treatment and Research Communications · 2026
  13. The rise of selective estrogen receptor modulators (SERMs) in breast cancer therapy: a promising horizonCancer Treatment and Research Communications · 2026
  14. Association of serum folate levels with mortality among cancer survivors: insights from NHANES 1999–2018Cancer Treatment and Research Communications · 2026
  15. Curcumin in pancreatic cancer: A comprehensive review of anticancer mechanisms, EMT modulation, and clinical challengesCancer Treatment and Research Communications · 2026
  16. Downregulated extracellular matrix-associated CILP, MFAP4, and MMRN1 genes reveal links to immune infiltration and clinical outcomes in colorectal cancer: bioinformatics and experimental validationCancer Treatment and Research Communications · 2026
  17. m6A RNA methylation in breast cancer: from epitranscriptomic regulation to therapeutic targetingCancer Treatment and Research Communications · 2026
  18. Nasolabial flap in head & neck reconstruction: a historical workhorse with modern relevanceCancer Treatment and Research Communications · 2026
  19. NLR-fat/NLR-muscle mass grading system significantly predicts survival in cancer patients: a multicenter cohort studyCancer Treatment and Research Communications · 2026
  20. Factors associated with diagnostic delay among patients with oral squamous cell carcinoma: a hospital-based observational studyCancer Treatment and Research Communications · 2026
  21. Associations of oxaliplatin dose, lean body mass, and sarcopenia with dose-limiting neuropathy in patients with colorectal cancerCancer Treatment and Research Communications · 2026
  22. An immune-metabolic transcriptomic balance stratifies acute myeloid leukemia and reveals distinct immunological and signaling dependenciesCancer Treatment and Research Communications · 2026
  23. LRRC15 in tumorigenesis, progression, and therapyCancer Treatment and Research Communications · 2026
  24. A GPC1-Targeting multifunctional nanoplatform combining paclitaxel-mediated chemotherapy and chlorin e6-assisted sonodynamic therapy for Pancreatic Ductal Adenocarcinoma (PDAC) treatmentCancer Treatment and Research Communications · 2026
  25. High expression of the multifunctional proto-oncogene BMI1 predicts poor outcome in high-grade serous carcinomaCancer Treatment and Research Communications · 2026
  26. A landscape analysis of Japanese tolerability assessments in oncology drug developmentCancer Treatment and Research Communications · 2026
  27. Clinicopathological features of LOXL1-expressing non-small cell lung cancer: relation to the extent of CD8+ T-cell infiltrationCancer Treatment and Research Communications · 2026
  28. The potential role of oligo-fucoidan as a bioactive adjunct in oncology: a personal view on mechanistic insights and therapeutic continuityCancer Treatment and Research Communications · 2026
  29. The Brain–tumor axis: Tumor pathogenesis and therapeutic strategies from a cancer neuroscience perspectiveCancer Treatment and Research Communications · 2026
  30. Baseline visceral adipose tissue radiodensity as biomarker of survival in advanced NSCLC treated with first-line single-agent immunotherapyCancer Treatment and Research Communications · 2026
  31. Exosomal Non-Coding RNAs: Emerging regulators of the tumor microenvironment in gastrointestinal and hepatobiliary cancersCancer Treatment and Research Communications · 2026
  32. Intracranial efficacy of combined immune checkpoint inhibitors and platinum plus etoposide therapy in patients with extensive-disease small-cell lung cancer and brain metastasesCancer Treatment and Research Communications · 2026
  33. Phase 1/2 trial of brigatinib plus panitumumab in patients with osimertinib-resistant EGFR-mutated non-small cell lung cancer harboring EGFR C797S mutationCancer Treatment and Research Communications · 2026
  34. Viral modulation of angiogenesis through microRNA networks: Implications for cancer biology, biomarkers, and therapyCancer Treatment and Research Communications · 2026
  35. An ICD gene set-derived immune contexture signature for colorectal cancer prognosis: integrated single-cell and bulk transcriptomic analysis with external validationCancer Treatment and Research Communications · 2026
  36. Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastasesCancer Treatment and Research Communications · 2026
  37. Clinical trajectories from first-line chemotherapy to best supportive care in unresectable pancreatic cancer: a 10-year real-world retrospective studyCancer Treatment and Research Communications · 2026
  38. Comprehensive analysis of global histone modification pattern with clinical features and therapeutic potential in gliomaCancer Treatment and Research Communications · 2026
  39. Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational studyCancer Treatment and Research Communications · 2026
  40. Radiotherapy strategies for prostate cancer: Techniques, outcomes, and patient careCancer Treatment and Research Communications · 2026
  41. A viable human lung cancer tissue collection (LCTC) to accelerate translational researchCancer Treatment and Research Communications · 2026
  42. The complex landscape of non-coding RNAs in olaparib response and resistanceCancer Treatment and Research Communications · 2026
  43. 183 Quality of life changes following treatment in patients with NSCLC: a systematic review and meta-analysisCancer Treatment and Research Communications · 2026
  44. Imaging modality, incidental detection, and age–stage distribution in surgically treated clear cell renal cell carcinomaCancer Treatment and Research Communications · 2026
  45. Long non-coding RNAs as biomarkers for diagnosis and prognosis in HPV-associated cervical cancer: A systematic scoping reviewCancer Treatment and Research Communications · 2026
  46. Incidental diagnosis of primary appendiceal follicular lymphoma following appendectomyCancer Treatment and Research Communications · 2026
  47. Relapse and progression after CAR-T cell therapy in large B-cell lymphoma: Patterns, mechanisms, and salvage strategiesCancer Treatment and Research Communications · 2026
  48. Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysisCancer Treatment and Research Communications · 2026
  49. RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancerCancer Treatment and Research Communications · 2026
  50. Coconut milk exosomal formulation of curcumin analog targets head and neck cancer progression through alterations in the HABP1 signaling mechanismCancer Treatment and Research Communications · 2026